Sarepta Therapeutics (SRPT) Free Cash Flow Growth (5y) (2015 - 2026)
Sarepta Therapeutics (SRPT) Free Cash Flow Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,192.35 Bn | 67,192.06 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - |
| 4 | BeOne Medicines | 471.52 Bn | 466.73 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.73 Bn | 114.48 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.88 Bn | 61.13 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.11 Bn | 63.11 Bn | - |
| 8 | Argenx Se | 55.88 Bn | 50.70 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - |
| 10 | Sarepta Therapeutics | 1.71 Bn | 1.31 Bn | 622.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.32% |
| Dec 31, 2025 | 21.32% |
| Sep 30, 2025 | 32.28% |
| Jun 30, 2025 | 30.68% |
| Mar 31, 2025 | -24.69% |
| Dec 31, 2024 | 18.11% |
| Sep 30, 2024 | -7.03% |
| Jun 30, 2024 | 31.70% |
| Mar 31, 2024 | -11.06% |
| Dec 31, 2023 | 12.37% |
| Sep 30, 2023 | -1.59% |
| Jun 30, 2023 | -2.16% |
| Mar 31, 2023 | -35.55% |
| Dec 31, 2022 | -23.48% |
| Sep 30, 2022 | -4.52% |
| Jun 30, 2022 | 2.92% |
| Mar 31, 2022 | -11.35% |
| Dec 31, 2021 | 17.82% |
| Sep 30, 2021 | -16.80% |
| Jun 30, 2021 | -21.36% |